MedTrace Logo

Project Insight: Feasibility of a Breast Cancer Screening Decision Support Tool

NCT04741503 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1277

Last updated 2022-09-28

Study results available
· View outcomes & findings →

Summary

The purpose of this investigation is to conduct a feasibility study to evaluate the potential for implementing the developed decision support tool with Latina, Black, and non-Latina White women. The investigators will collect feasibility data and assess the use of the decision support tool with end-users. The aim is to determine if women using the decision support tool make more informed choices measured by knowledge, attitudes, and intentions.

Conditions

  • Breast Cancer Screening
  • Oncology
  • Preventative Medicine
  • Mammography

Interventions

OTHER

Breast Cancer Screening Decision Support Tool

-Provides a description of screening mammography, current screening recommendations, benefits and downsides, narratives, and questions for the participant's physician.

OTHER

National Cancer Institute Breast Cancer Screening PDQ

-Provides current information about breast cancer screening and is meant to inform and help patients

Sponsors & Collaborators

  • National Institute on Minority Health and Health Disparities (NIMHD)

    collaborator NIH

  • Washington University School of Medicine

    lead OTHER

Principal Investigators

  • Ashley J Housten, OTD, MSCI · Washington University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-04-19
Primary Completion
2021-08-30
Completion
2021-08-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04741503 on ClinicalTrials.gov